These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 1541322

  • 1. Pharmacokinetics of IV and oral acetyl-L-carnitine in a multiple dose regimen in patients with senile dementia of Alzheimer type.
    Parnetti L, Gaiti A, Mecocci P, Cadini D, Senin U.
    Eur J Clin Pharmacol; 1992; 42(1):89-93. PubMed ID: 1541322
    [Abstract] [Full Text] [Related]

  • 2. HPLC determination and pharmacokinetics of endogenous acetyl-L-carnitine (ALC) in human volunteers orally administered a single dose of ALC.
    Kwon OS, Chung YB.
    Arch Pharm Res; 2004 Jun; 27(6):676-81. PubMed ID: 15283472
    [Abstract] [Full Text] [Related]

  • 3. Comparison of pharmacokinetics of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine after single oral administration of L-carnitine in healthy volunteers.
    Cao Y, Wang YX, Liu CJ, Wang LX, Han ZW, Wang CB.
    Clin Invest Med; 2009 Feb 01; 32(1):E13-9. PubMed ID: 19178874
    [Abstract] [Full Text] [Related]

  • 4. Homeostatic equilibrium of L-carnitine family before and after i.v. administration of propionyl-L-carnitine in humans, dogs and rats.
    Marzo A, Cardace G, Corbelleta C, Bassani E, Morabito E, Arrigoni Martelli E.
    Eur J Drug Metab Pharmacokinet; 1991 Feb 01; Spec No 3():357-63. PubMed ID: 1820908
    [Abstract] [Full Text] [Related]

  • 5. [Acetyl-L-carnitine (carnicetine) in the treatment of early stages of Alzheimer's disease and vascular dementia].
    Gavrilova SI, Kalyn IaB, Kolykhalov IV, Roshchina IF, Selezneva ND.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011 Feb 01; 111(9):16-22. PubMed ID: 22027664
    [Abstract] [Full Text] [Related]

  • 6. Metabolism and disposition of intravenously administered acetyl-L-carnitine in healthy volunteers.
    Marzo A, Arrigoni Martelli E, Urso R, Rocchetti M, Rizza V, Kelly JG.
    Eur J Clin Pharmacol; 1989 Feb 01; 37(1):59-63. PubMed ID: 2591464
    [Abstract] [Full Text] [Related]

  • 7. Ameliorative Effect of Acetyl L-carnitine in Alzheimer's Disease via Downregulating of Homocysteine Levels in Hyperhomocysteinemia Induced Cognitive Deficit in Mouse Model.
    Verma N, Gupta JK, Varshney KK, Srivastava R.
    Drug Metab Lett; 2021 Feb 01; 14(3):219-231. PubMed ID: 34886786
    [Abstract] [Full Text] [Related]

  • 8. Acetyl-L-carnitine.
    Altern Med Rev; 1999 Dec 01; 4(6):438-41. PubMed ID: 10608918
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of propionyl-L-carnitine in humans: evidence for saturable tubular reabsorption.
    Pace S, Longo A, Toon S, Rolan P, Evans AM.
    Br J Clin Pharmacol; 2000 Nov 01; 50(5):441-8. PubMed ID: 11069438
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Urinary excretion of L-carnitine and its short-chain acetyl-L-carnitine in patients undergoing carboplatin treatment.
    Mancinelli A, D'Iddio S, Bisonni R, Graziano F, Lippe P, Calvani M.
    Cancer Chemother Pharmacol; 2007 Jun 01; 60(1):19-26. PubMed ID: 16988826
    [Abstract] [Full Text] [Related]

  • 12. Intravenous L-carnitine and acetyl-L-carnitine in medium-chain acyl-coenzyme A dehydrogenase deficiency and isovaleric acidemia.
    Van Hove JL, Kahler SG, Millington DS, Roe DS, Chace DH, Heales SJ, Roe CR.
    Pediatr Res; 1994 Jan 01; 35(1):96-101. PubMed ID: 8134205
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of oral acetyl-L-carnitine in renal impairment.
    Kelly JG, Hunt S, Doyle GD, Laher MS, Carmody M, Marzo A, Arrigoni Martelli E.
    Eur J Clin Pharmacol; 1990 Jan 01; 38(3):309-12. PubMed ID: 2340852
    [Abstract] [Full Text] [Related]

  • 14. [A controlled randomized trial of the use of combined L-carnitine and acetyl-L-carnitine treatment in men with oligoasthenozoospermia].
    Li Z, Chen GW, Shang XJ, Bai WJ, Han YF, Chen B, Teng XM, Meng FH, Zhang B, Chen DN, Liu JH, Zheng XM, Cao XR, Liu Y, Zhu XB, Wang YX.
    Zhonghua Nan Ke Xue; 2005 Oct 01; 11(10):761-4. PubMed ID: 16281510
    [Abstract] [Full Text] [Related]

  • 15. Clinical pharmacokinetics of drugs for Alzheimer's disease.
    Parnetti L.
    Clin Pharmacokinet; 1995 Aug 01; 29(2):110-29. PubMed ID: 7586900
    [Abstract] [Full Text] [Related]

  • 16. Acetyl-L-carnitine and Alzheimer's disease: pharmacological considerations beyond the cholinergic sphere.
    Carta A, Calvani M, Bravi D, Bhuachalla SN.
    Ann N Y Acad Sci; 1993 Sep 24; 695():324-6. PubMed ID: 8239306
    [Abstract] [Full Text] [Related]

  • 17. Double-blind, placebo controlled study of acetyl-l-carnitine in patients with Alzheimer's dementia.
    Rai G, Wright G, Scott L, Beston B, Rest J, Exton-Smith AN.
    Curr Med Res Opin; 1990 Sep 24; 11(10):638-47. PubMed ID: 2178869
    [Abstract] [Full Text] [Related]

  • 18. Effect of acetyl-L-carnitine treatment on the levels of levocarnitine and its derivatives in streptozotocin-diabetic rats.
    Marzo A, Corsico N, Cardace G, Morabito E.
    Arzneimittelforschung; 1993 Mar 24; 43(3):339-42. PubMed ID: 8489564
    [Abstract] [Full Text] [Related]

  • 19. The effect of acetyl-L-carnitine administration on persons with Down syndrome.
    Pueschel SM.
    Res Dev Disabil; 2006 Mar 24; 27(6):599-604. PubMed ID: 16621446
    [Abstract] [Full Text] [Related]

  • 20. Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease.
    Pettegrew JW, Klunk WE, Panchalingam K, Kanfer JN, McClure RJ.
    Neurobiol Aging; 1995 Mar 24; 16(1):1-4. PubMed ID: 7723928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.